Your browser doesn't support javascript.
loading
Efficacy and Safety of Tyrosine Kinase Inhibitors Alone or Combination with Programmed Death-1 Inhibitors in Treating of Hepatitis C-Related Hepatocellular Carcinoma.
Lei, Jin; Yang, Sibo; Chen, Bowen; Zhang, Linzhi; Yan, Tao; Yang, Gangqi; Chen, Yue; Li, Yinyin; Lu, Yinying; Zuo, Shi.
Afiliación
  • Lei J; School of Clinical Medicine, Guizhou Medical University, Guiyang, People's Republic of China.
  • Yang S; School of Clinical Medicine, Guizhou Medical University, Guiyang, People's Republic of China.
  • Chen B; 302 Clinical Medical School, Peking University, Beijing, People's Republic of China.
  • Zhang L; Comprehensive Liver Cancer Center, the 5th Medical Center of the PLA General Hospital, Beijing, People's Republic of China.
  • Yan T; Comprehensive Liver Cancer Center, the 5th Medical Center of the PLA General Hospital, Beijing, People's Republic of China.
  • Yang G; School of Clinical Medicine, Guizhou Medical University, Guiyang, People's Republic of China.
  • Chen Y; School of Clinical Medicine, Guizhou Medical University, Guiyang, People's Republic of China.
  • Li Y; Comprehensive Liver Cancer Center, the 5th Medical Center of the PLA General Hospital, Beijing, People's Republic of China.
  • Lu Y; School of Clinical Medicine, Guizhou Medical University, Guiyang, People's Republic of China.
  • Zuo S; Comprehensive Liver Cancer Center, the 5th Medical Center of the PLA General Hospital, Beijing, People's Republic of China.
J Hepatocell Carcinoma ; 10: 357-367, 2023.
Article en En | MEDLINE | ID: mdl-36891505
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Idioma: En Revista: J Hepatocell Carcinoma Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Idioma: En Revista: J Hepatocell Carcinoma Año: 2023 Tipo del documento: Article